Inflammatory Markers During Early Treatment of Seroconverters in a Randomized Placebo-Controlled Trial of PrEP (ANRS-IPERGAY)

HIV-related inflammation is associated with poor outcomes. We describe inflammatory biomarkers in 17 participants in a pre-exposure prophylaxis trial who seroconverted with very early initiation of antiretroviral therapy. Inflammation peaked at the time of HIV infection and returned to baseline with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chawki, Sylvain, Charreau, Isabelle, Gabassi, Audrey, Carette, Diane, Cua, Eric, Cotte, Laurent, Pialoux, Gilles, Pintado, Claire, Meyer, Laurence, Chaix, Marie-Laure, Delaugerre, Constance, Molina, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990514/
https://www.ncbi.nlm.nih.gov/pubmed/33796598
http://dx.doi.org/10.1093/ofid/ofab085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990514/
https://www.ncbi.nlm.nih.gov/pubmed/33796598
http://dx.doi.org/10.1093/ofid/ofab085

Ejemplares similares